ArticleTherapeutic advances in gastroenterology2019

The irreversible HCV-associated risk of gastric cancer following interferon-based therapy: a joint study of hospital-based cases and nationwide population-based cohorts.

Chun-Wei Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.